[go: up one dir, main page]

ES3003888T3 - Blood purification by alkalinizing agent - Google Patents

Blood purification by alkalinizing agent Download PDF

Info

Publication number
ES3003888T3
ES3003888T3 ES18787098T ES18787098T ES3003888T3 ES 3003888 T3 ES3003888 T3 ES 3003888T3 ES 18787098 T ES18787098 T ES 18787098T ES 18787098 T ES18787098 T ES 18787098T ES 3003888 T3 ES3003888 T3 ES 3003888T3
Authority
ES
Spain
Prior art keywords
concentration
urine
pharmaceutical composition
sulfate
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18787098T
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tohoku University NUC
Nippon Chemiphar Co Ltd
Original Assignee
Tohoku University NUC
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2017085741A external-priority patent/JP7578234B2/ja
Application filed by Tohoku University NUC, Nippon Chemiphar Co Ltd filed Critical Tohoku University NUC
Application granted granted Critical
Publication of ES3003888T3 publication Critical patent/ES3003888T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Polymers & Plastics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES18787098T 2017-04-18 2018-03-13 Blood purification by alkalinizing agent Active ES3003888T3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2017082423 2017-04-18
JP2017085741A JP7578234B2 (ja) 2017-04-18 2017-04-24 アルカリ性化剤による血液浄化
JP2017103935 2017-05-25
PCT/JP2017/032931 WO2018193648A1 (ja) 2017-04-18 2017-09-12 アルカリ性化剤による血液浄化
PCT/JP2018/009679 WO2018193752A1 (ja) 2017-04-18 2018-03-13 アルカリ性化剤による血液浄化

Publications (1)

Publication Number Publication Date
ES3003888T3 true ES3003888T3 (en) 2025-03-11

Family

ID=63855742

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18787098T Active ES3003888T3 (en) 2017-04-18 2018-03-13 Blood purification by alkalinizing agent

Country Status (5)

Country Link
JP (1) JP7525868B2 (ja)
KR (1) KR102773144B1 (ja)
ES (1) ES3003888T3 (ja)
TW (1) TWI847827B (ja)
WO (2) WO2018193648A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019361520B2 (en) 2018-10-17 2025-04-24 Nippon Chemiphar Co., Ltd. Novel pharmaceutical composition
WO2020080451A1 (ja) * 2018-10-17 2020-04-23 京都府公立大学法人 糖尿病腎症における腎線維化抑制剤
WO2020222302A1 (ja) 2019-04-28 2020-11-05 国立大学法人東北大学 新規医薬組成物
CN112839678A (zh) * 2019-07-18 2021-05-25 德尔塔菲制药股份有限公司 抗癌剂的效果增强剂
PH12022552490A1 (en) 2020-03-26 2024-04-22 Nippon Chemiphar Co Renal function protectant
TW202308604A (zh) * 2021-05-10 2023-03-01 國立大學法人東北大學 肌肉量增加用組成物
TW202448422A (zh) 2023-02-24 2024-12-16 日商日本化美化股份有限公司 末梢神經障礙之治療或預防用的醫藥
TW202438042A (zh) 2023-02-24 2024-10-01 日商日本化美化股份有限公司 化學療法誘發末梢神經障礙之治療或預防用的醫藥

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60105619A (ja) * 1983-11-15 1985-06-11 Nippon Chemiphar Co Ltd 尿アルカリ化性食品組成物
JPS60197624A (ja) * 1984-03-21 1985-10-07 Nippon Chemiphar Co Ltd 尿アルカリ化性食品組成物
JP4087929B2 (ja) * 1997-08-27 2008-05-21 日清ペットフード株式会社 猫慢性腎不全治療用組成物及びその治療方法
AU2007210090B2 (en) * 2006-01-30 2013-08-22 Panion & Bf Biotech Inc. Method of treating chronic kidney disease
JP2007217366A (ja) * 2006-02-17 2007-08-30 Kirin Brewery Co Ltd 尿酸値降下用組成物
JP5197846B2 (ja) * 2009-04-30 2013-05-15 紀陽 田仲 腎疾患重篤度を判定する方法又は装置若しくはその作動方法
JP6164719B2 (ja) * 2009-10-27 2017-07-19 エイワイファーマ株式会社 白金含有薬剤投与による腎障害の軽減剤
JP5837879B2 (ja) * 2010-07-05 2015-12-24 株式会社明治 腸内腐敗物質の低減作用を有するビフィズス菌
MX357998B (es) 2015-03-20 2018-07-11 Antonio Hernandez Miramontes Jorge Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo.
JP6490614B2 (ja) * 2015-03-30 2019-03-27 景博 内田 インドキシル硫酸の測定方法
JP2017082423A (ja) 2015-10-23 2017-05-18 信越ポリマー株式会社 トリム部材、及び該トリム部材を用いた施工方法
JP2017085741A (ja) 2015-10-27 2017-05-18 住友電装株式会社 ワイヤハーネスの外装材
JP2017103935A (ja) 2015-12-02 2017-06-08 田淵電機株式会社 分散型電源のシステム制御装置、及びパワーコンディショナ

Also Published As

Publication number Publication date
JP2023022079A (ja) 2023-02-14
TW202345784A (zh) 2023-12-01
KR20240110103A (ko) 2024-07-12
TWI847827B (zh) 2024-07-01
WO2018193648A1 (ja) 2018-10-25
JP7525868B2 (ja) 2024-07-31
KR102773144B1 (ko) 2025-02-25
WO2018193752A1 (ja) 2018-10-25

Similar Documents

Publication Publication Date Title
ES3003888T3 (en) Blood purification by alkalinizing agent
JP2023115271A (ja) アルカリ性化剤による血液浄化
AU2019361520B2 (en) Novel pharmaceutical composition
JP7482033B2 (ja) 夜間多尿の治療又は予防剤
KR20220164517A (ko) 신장 기능 보호제
EP3868215A1 (en) Agent for improving quality of sleep
WO2020222302A1 (ja) 新規医薬組成物
HK40079287A (en) Renal function protectant
JP5076327B2 (ja) 分岐鎖アミノ酸の心不全適応
Tablets et al. Pr TEVA-IRBESARTAN